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Abstract
The process of cell division in mammalian cells is orchestrated by cell-cycle-dependent
oscillations of the cyclin protein levels. Cyclin levels are controlled by redundant
transcriptional, post-translational and degradation feedback loops. How each of
these separate loops contributes to the regulation of the key cell cycle events and
to the connection between the G1-S transition and the subsequent mitotic events
is under investigation. Cdc20 homologue 1 (Cdh1), well-known for controlling G1
phase progression, is emerging as an important regulator of DNA synthesis and mi-
tosis. Here, we present an integrated computational model of the mammalian cell
cycle based on the sequential activation of cyclins. We dissect the emergent role of
Cdh1 as a universal regulator of the cell cycle. We validate the model against exper-
imental data on liver cells (hepatocytes) during liver regeneration, which undergo
one or two rounds of synchronous circadian-clock gated cell divisions. Our model
is coherent with the notion that the mitotic exit in mammalian cells is bistable
and suggests Cdh1 as a key regulator of mitosis. We suggest that Cdh1 plays an
important role in controlling cell cycle events during G2 and mitosis phases.
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1 Introduction
The cell division cycle is a highly organized and structured mechanism in
mammals. Because of its dynamical nature, it has been subject to several
computational models. First computational models pertained to the cell cycle
in amphibian embryos and yeast (Tyson, 1991; Goldbeter, 1991; Novak and
Tyson, 1993; Sha et al., 2003; Pomerening et al., 2003; Chen et al., 2004).
More recently, computational models were proposed for specific parts of the
mammalian cell cycle, particularly the G1/S phase transition and the restric-
tion point (Aguda and Tang, 1999; Qu et al., 2003a,b; Swat et al., 2004; Novak
and Tyson, 2004). A generic model for the eukaryotic cell cycle has also been
presented (Csikasz-Nagy et al., 2006).
Few detailed, integrative models coupling the main events of the cell cycle,
DNA synthesis and mitosis have been proposed. Models of this sort have been
proposed for yeast, in which growth of cell mass is playing a key role in regu-
lating mitosis (Chen et al., 2004), and more recently for mammals (Gerard and
Goldbeter, 2009). In mammals, however, cell mass is not a major determining
factor for the control of cell cycle. Rather, mammalian cells possess multiple
control mechanisms that prevent them from proliferating outside specific con-
ditions. Mammalian cells vary in type and degree of differentiation, each one
having different proliferative potential and mechanism. This makes the task of
modelling mammalian cells challenging, as there is no universal experimental
model. In vitro systems of dividing cells provide a way to study synchronized
cell populations, which are suitable for modelling cell cycle events. However,
cell cycle specific events are obtained under variable experimental conditions
and different cell cycle synchronization procedures, which are difficult to re-
produce on models. During liver regeneration, liver cells (hepatocytes) divide
in a highly synchronized manner. We have taken advantage of the wealth of
experimental data on the cell cycle during liver regeneration to construct the
first integrative model of the mammalian cell cycle in the regenerating livers.
Liver regeneration is a process by which the liver can recover its normal mass
and function following injury. After the surgical removal of two-third of the
liver (partial hepatectomy), 90 % of the hepatocytes re-enter the cell cycle
synchronously to complete 1 or 2 divisions and restore the liver mass. Partial
hepatectomy (PH) triggers the release of pro-inflammatory cytokines (PIC).
In the presence of PIC, hepatocytes leave a quiescent state, denoted G0, to
enter a primed state, a process denoted priming. Primed cells, which are in the
early G1 phase, are then driven by growth factors (GFs) to cross the restric-
tion point, a point of no return beyond which they are irreversibly engaged in
the cell cycle and do not require growth factors any more to complete mitosis
(Taub, 2004). Progression within the cell cycle is controlled by the sequential
activation of a family of cyclin dependent kinases (cdks) that allow an ordered
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succession of the cell cycle phases: G1, S, G2, and M (Morgan, 2007). The cdk
proteins are only active when they form a complex with their corresponding
cyclin proteins. Cyclin D/Cdk4-6, Cyclin E/Cdk2, Cyclin A/Cdk2, and Cy-
clin B/Cdk1 complexes promote, respectively, progression in G1 phase, the
transition from G1 to S phase, progression in S and G2 phase, and finally
the G2/M phase transition, allowing entry into mitosis (Morgan, 2007). Cy-
clin/cdk complexes are the workhorses of the cell cycle machinery, and as
such, they need regulators. Cyclin/cdk regulation, which we henceforth men-
tion as cyclin regulation for simplicity, is achieved through a variety of mech-
anisms. These include transcriptional regulation [E2F transcription factor 1
(E2F)], association with protein inhibitors [cyclin dependent kinase inhibitor
(CKI)], phosphorylation/dephosphorylation [Wee1 and cell division cycle 25
(Cdc25)] and cyclin degradation [complexes formed with anaphase promot-
ing complex (APC) and Cdc20 homologue 1 (Cdh1) or Cell division cycle 20
(Cdc20) (APCCdh1, APCCdc20), Skp1/cullin/F-box protein related complexes
(SCF)] (Morgan, 2007)(Fig. 1).
2 The model
DNA synthesis and mitosis. After both PH and CCl4 treatment, liver
regeneration exhibits well-synchronized DNA synthesis and mitosis (Deguchi
et al., 2002). The temporal proliferation pattern of the cells in regenerating
rodent livers consists of two waves of mitosis (Fabrikant, 1968). During the
first round, hepatocytes synchronously undergo DNA replication and mitosis.
It is then followed by a second round of division of less synchrony (Faktor,
1971). In mice, the first peak of DNA synthesis occurs 36 hours after PH and
the mitotic peak, 4-12 hours after the peak of DNA synthesis (Matsuo et al.,
2003).
E2Fs regulating sequential activation of cyclins. E2F activity is tightly
controlled by binding to the retinoblastoma protein (Rb). Rb sequesters E2F
and inhibits its transcriptional activity. Cyclins sequentially phosphorylate Rb
and activate E2F in a positive feedback loop manner. Only hyperphosphory-
lated forms of Rb-E2F transactivates Cyclin A and Cyclin B (Lundberg and
Weinberg, 1998) (see Appendix A.2 for the derivation of the Rb/E2F equa-
tions).
CKI at the interphase of S phase and mitosis. CKI stoichiometrically
inhibits Cyclin D, Cyclin E and Cyclin A by forming complexes with their
cdk partners (Harper et al., 1995). CKIs are predominantly transcriptionally
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regulated by cytokine-dependent signaling (Gartel and Tyner, 1999; Coller
et al., 2000). For further details on modelling CKI activation refer to (Chauhan
et al., 2008). Degradation of CKI is mediated by SCF and APC-Cdc20 (Bashir
et al., 2004; Amador et al., 2007). For simplicity, we do not model SCF and/or
APC-Cdc20 dependent degradation of CKI, but use a general degradation
term for CKI.
Cyclins. The whole process of cell division is orchestrated by the sequential
activation of cyclins. Cyclin D and Cyclin E are the G1-S cyclins that trigger
DNA synthesis. G1-S cyclins are induced by cytokine- and growth factor-
dependent pathways and their degradation is controlled by SCF. For further
details on Cyclin D and Cyclin E modelling refer to (Chauhan et al., 2008).
The rise of G1-S cyclins is accompanied by the appearance of Cyclin A during
S phase. In the late G2 phase, a transient activation of Cyclin B is observed
enabling swift G2-M transition. This transient activation is enabled by reg-
ulatory feedbacks imposed on Cyclin B by Cdc25 and Wee1. At metaphase,
sufficiently high levels of active Cyclin B phosphorylates Cdc20 to form an
active complex with APC, which in turn, degrades Cyclin B. Inactivation of
Cyclin B allows mitotic exit and return to the G1 phase (Morgan, 2007). In-
activation of Cyclin B also leads to dephosphorylated Cdh1 which then forms
an active complex with APC to degrade Cyclin B and Cyclin A during G1
phase.
APC and SCF: the degradators controlling the cell cycle APC is a
proteasomal degradation machinery that needs to form complexes with sub-
units to be activated. During the cell cycle, APC is successively activated by
two of its subunits, Cdc20 and Cdh1, which have separate windows of activ-
ity, each regulated by feedback loops. Cdc20 is activated by Cyclin B during
mitosis through a negative feedback loop. Cdh1 becomes active at the end
of mitosis through a positive feedback loop, when Cyclin B is degraded, and
assembles with APC to further degrade Cyclin A, Cyclin B, Cdc20 and SCF
(Wasch et al., 2010). Cdh1 also acts as a G1 regulator by destroying mitotic
cyclins during G1 phase and maintaining the cell in G1 by the destruction of
SCF (Bashir et al., 2004; Wei et al., 2004). Cdh1 controls Cyclin A and B at
two levels: first by a direct cyclin-Cdh1 double feedback loop and second by a
CyclinB-Cdc20 negative feedback. Cdh1 controls G1 cyclins, Cyclin D and E
by degrading their degradator SCF.
SCF can degrade G1-S cyclins, Cyclin D and Cyclin E (Yu et al., 1998;
Nakayama and Nakayama, 2005). SCF is down-regulated during M and G1
phases and is induced by Cyclin E near the S phase when its degradator
Cdh1 is degraded (Bashir et al., 2004). Cdh1 connects the SCF-driven G1-S
proteolytic machinery with the APC-dependent mitotic and G1 proteolysis.
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Therefore, at the core of the cell cycle lies Cdh1-driven degradation that re-
sults in a proteolytic oscillator setting the pace of the cell cycle progression.
Using the existing knowledge about cyclin control mechanisms and their tem-
poral organization during liver regeneration, we designed the network control-
ling the cyclin-dependent kinase activity at all stages of the cell cycle (Fig. 1).
The model is a system of ordinary differential and algebraic equations describ-
ing the concentration of key players of the cell cycle (See Appendix A for a
description of the model variables). To make the model as tractable as possible,
the variables were sorted according to the time scale on which they evolve. The
time-scale of reference is the duration of one cell cycle (in hours). Variables
that change on a shorter time-scale were approximated by their steady state
(quasi-steady state assumption). For instance, concentrations of phosphory-
lated proteins were approximated by their steady states. To limit the number
of variables in the model, we considered explicitly protein concentrations but
not their corresponding mRNA concentrations. The kinetic parameters (see
Appendix B) were adjusted so that the model could represent the experi-
mentally observed temporal dynamics of respective model species. The induc-
tion of gene expression by pro-inflammatory cytokines, growth factors and by
Rb-E2F (here called E2F) was incorporated directly by time-dependent in-
put functions modulating the synthesis of cyclins (see (Chauhan et al., 2008)
and Appendix A.2). Post-translational regulation through phosphorylation-
dephosphorylation or through complex formation is explicitly included in the
model. For simplicity, we do not distinguish between the nuclear and cytosolic
compartments of the cell. The model describes the dynamics of the intracel-
lular cyclin/cdk network and represents an average hepatocyte during liver
regeneration. Our aim is to address one cycle of division during liver regen-
eration triggered by a decaying damage (Hayashi et al., 2003; Blindenbacher
et al., 2003). All concentrations in the model are expressed in arbitrary units
(a.u.) since for most of the regulatory proteins, the actual concentrations are
not known.
Numerical simulations of the full model were performed with Matlab. Bistabil-
ity analysis of the model was done with the numerical bifurcation continuation
process of XPPAUT.
3 Results
3.1 Sequential activation of cyclins and proteolytic degradators
The computational model is able to reproduce the sequential activation of
cyclins and proteolytic degradators along the cell cycle (Fig. 2). Damage ac-
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tivates cytokine- and growth factor-induced pathways which lead to the acti-
vation of Cyclin D during late G1 and the subsequent activation of Cyclin E,
indicating entry into S phase (Chauhan et al., 2008). Step-wise activation of
E2F via Cyclin D and Cyclin E leads to the sequential transcription of Cyclin
A in the S phase and Cyclin B during mitosis (Morgan, 2007) (for equations
see Appendix A.2). CKI is activated in early G1 and is maximally elevated
at late S phase (Behrens et al., 2002). E2F activity peaks at S phase (Chen
et al., 2009). APCCdh1 is active during late mitosis and early G1 phase, de-
grading Cyclin A and Cyclin B. APCCdc20, which is a degradator of mitotic
substrates, is activated during late mitosis, once Cyclin B is sufficiently acti-
vated. Degradator of G1-S cyclins, SCF, becomes active at the end of S phase,
leading to the degradation of Cyclin D and Cyclin E . Also, mitotic regula-
tors Cyclin B active, Wee1, Cdc25 and APCCdc20 exhibit a delayed switch-like
activation (Morgan, 2007) (Fig. 2).
3.2 A switch in Cyclin B activity drives M phase progression
A switch-like increase in the activity of Cyclin B enables entry into mitosis,
whereas subsequent Cyclin B proteolysis promotes exit from mitosis (Morgan,
2007). This switch-like behavior is made possible by the presence of controls
on Cyclin B activation, which conserves the total amount of Cyclin B, and on
total Cyclin B concentration.
Two feedback loops control Cyclin B activity: a double negative feedback loop
from the inhibitory kinase Wee1, which is itself inhibited by Cyclin B, and a
positive feedback loop from the activating phosphatase Cdc25, which is further
activated by Cyclin B (Tyson et al., 2003). Recently, Potapova et al. (2009)
have shown that the exit from mitosis was also a switch phenomenon, due
to the Wee1 and Cdc25-dependent positive feedback loops acting during G1
phase.
Total Cyclin B concentration is controlled through synthesis, by E2F, and
degradation, by APCCdh1 and APCCdc20. E2F promotes Cyclin B synthesis. At
low E2F activity, there is not enough Cyclin B for any of it to be activated. If
E2F reaches a threshold value, Cyclin B gets activated. This threshold activa-
tion is achieved through a transcritical bifurcation (Fig. 3 (a)) (Guckenheimer
and Holmes, 1997). At any E2F values, two steady states for Cyclin B exist,
one zero and one either negative (below the threshold) or positive (above the
threshold). The zero steady state is stable below the threshold and the positive
steady state is stable above it. This transcritical bifurcation is possible because
of the Cdc25 loop. When this loop is switched off by setting Cdc25 to a low
constant level (set at 0.01), the transcritical bifurcation disappears. No effect
was observed when Wee1 loop was removed (results not shown). APCCdh1 is
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responsible for the activation of Cyclin B by a double negative feedback loop
regulation, while APCCdc20 is mainly responsible for its degradation at the
exit of mitosis. Varying the strength of the degradation rate dCdh1CB revealed
a bistable switch that allows rapid activation and inactivation of Cyclin B
(Fig. 3 (b)). At high degradation rate, there is a small total amount of Cyclin
B, and no active Cyclin B. When the degradation rate is reduced, a second
stable steady state appears through a saddle-node bifurcation. These two sta-
ble steady states co-exist until the low level steady state becomes unstable,
through a reverse pitchfork bifurcation (Guckenheimer and Holmes, 1997).
For degradation rates below that level, there is only high Cyclin B activity.
This combination of bifurcations form a bistable switch whereby low and high
levels of Cyclin B are possible.
Thus, our model includes two mechanisms for controlling Cyclin B activity:
a transcritical activation by E2F and a bistable switch induced by APCCdh1-
mediated Cyclin B degradation. The transcritical activation ensures active
Cyclin B levels remain to zero whenever total Cyclin B level are low, therefore
preventing accidental entry into mitosis. The bistable switch is responsible
for the rapid activation of Cyclin B at the entry to mitosis, and its rapid
elimination at the end of mitosis.
3.3 Liver regeneration and cell cycle progression are robust processes
Liver regeneration is a robust process. After PH, the liver grows back to its
normal mass even in the absence of important cell cycle players. Therefore we
expect Cyclin E and Cyclin B activity, as a measure of total DNA synthesis
and mitosis respectively, to be robustly activated. We analysed the sensitivity
of Cyclin E and Cyclin B activity with respect to changes in biochemical pa-
rameters. Both Cyclin E and Cyclin B were robust to parameter change except
when parameters immediately downstream of the damage, such as degrada-
tion of PIC, were varied. In case of these sensitive parameters, Cyclin E and
Cyclin B peaks showed a bell-shaped response to systematic variation in these
sensitive parameters (results now shown).
We further went on to study the response of the model to systematic changes
in the damage. We varied the damage from strong-transient to weak-sustained
input keeping the the total amount of damage, i.e. the integral under the curve,
constant. Both DNA synthesis (Cyclin E) and mitosis (Cyclin B) responded
as a bandpass filter to such a systematic variation in damage (Fig. 4a-b, upper
panels). Weak-sustained and strong-transient damages were rejected and the
cells did not progress through both DNA synthesis and mitosis in both cases.
The timing of cell cycle events was robust to varying nature of damage (Fig. 4a-
b, lower panels).
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Bandpass filtering properties have been studied previously in a G1/S model
(Chauhan et al., 2008). The damage was transmitted through two pathways:
1) direct ultrasensitive induction of Cyclin E, which filtered out the weak-
sustained damages; and 2) Cytokine mediated delayed pathway, which con-
sisted of nested feedforward loops. Incoherent feedforward loops via CKI and
HGF filtered out sharp-transient damages. In the present model, changing the
strength of feedback loops during G2/M/G1 phases did not change bandpass
filtering behaviour of the model. However, the range of the bandpass filter was
affected. Decreasing the positive feedback loop strength of the Cdh1-Cyclin
A loop by reducing the two Cyclin A and Cdh1 mutual negative regulation
parameters to one-half, one-fourth and zero respectively, had two distinct fil-
tering effects: it decreased the range of the filter in case of Cyclin B, while for
Cyclin E, it increased the range of filter (Fig. 5). This opposing control of cell
cycle events: DNA synthesis (Cyclin E) and mitosis (Cyclin B) with respect
to varying damage, has not been systematically studied to our knowledge.
3.4 The circadian clock gates mitosis but not DNA synthesis
Cell division in many mammalian tissues is associated with the circadian clock,
a ∼24 h rhythm regulating physiology and behaviour (Reppert and Weaver,
2002). In hepatocytes, Wee1 is the gatekeeper of this circadian control of cell
cycle (Matsuo et al., 2003). Wee1 is a clock-controlled gene (its expression
is modulated over 24 h), and regulates the timing and efficiency of the cell
cycle. In mice hepatocytes, Wee1 synthesis peaks around ZT12 (ZT0 represents
lights on and ZT12, lights off, in a 24 h light-dark cycle) (Matsuo et al.,
2003). To simulate the circadian expression of Wee1, we used a sinusoidal-
shaped synthesis rate of Wee1, with a maximal synthesis rate at ZT12 (See
Appendix A.6). We simulated PHs performed on mice at ZT8 or ZT0, and
used peak of activity in Cyclin B and E as markers of mitosis and S phase. We
found that mitotic activity induced by Cyclin B at ZT8 or ZT0 changes from
44.5 to 51.5 hours (Fig. 6). These results reproduce well the gating properties
of Wee1 observed experimentally (Matsuo et al., 2003).
In our model, DNA synthesis is directly coupled to mitosis via a Cdh1-SCF
loop. Nevertheless, Cyclin E activity, which is representative of DNA replica-
tion, was independent from Zeitgeber time PH (Fig. 6). Imposition of circa-
dian control on Wee1 maintains DNA synthesis as an independently controlled
property of hepatocytes (Matsuo et al., 2003).
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3.5 HGF treatment at S phase causes G2 delay
Growth factors are well known to promote the transition from G1 to S phase
in cell cycle progression. Beyond G1-S transition, however, growth factors have
been considered non-essential for the progression of the cell cycle (Jones and
Kazlauskas, 2001). Yet, when injected at S phase, hepatocyte growth factor
induces a G2 delay (Park et al., 2007). This delay is marked by a delayed
degradation of Cyclin A and Cyclin B, resulting in a delayed mitotic entry.
It is not very intuitive how HGF induction at S phase might lead to delayed
degradation of Cyclin A and Cyclin B. CKI up-regulation has been implicated
in this delay (Park et al., 2007). We simulated growth factor induction at
S phase by giving an extra HGF pulse during S phase between 36 and 40
hours (See Appendix A.7). Our model was able to reproduce the observed
delay in the degradation of Cyclin A and Cyclin B representing a G2 delay
(Fig. 7 (e-f)). Our simulations suggest that HGF treatment at S phase delays
APCCdh1 up-regulation and prolongs E2F activation. Thus, HGF induction
at S phase might also prolong E2F mediated mitotic transcription and hence
Cyclin A activation. As long as Cyclin A is active at G2, APCCdh1 can not be
activated due to its antagonistic control by Cyclin A. This leads to delayed
Cdh1 activation. Delayed Cdh1 activation leads to delayed degradation of
Cyclin A and Cyclin B (Fig. 7 (b-d)).
4 Discussion
Computational Model for Mammalian Cell Cycle
We have developed a computational model for the cell cycle of hepatocytes
during liver regeneration that couples different cyclins and proteolytic degrada-
tors in a sequential manner. We introduced Cdh1 as a universal controller of
the cell cycle. Recent experimental data have identified Cdh1 as a major con-
troller of cell cycle progression.
The model recapitulates the temporal profile of dividing hepatocytes follow-
ing partial hepatectomy: the sequential activation of cyclins and proteolytic
degradators; the effect of the circadian clock on the timing of mitosis; the G2
phase delay caused by HGF treatment during S phase and the effect of Cdh1
on cell cycle progression.
Gerard and Goldbeter (2009) recently presented a mammalian cell cycle model
describing the sequential cyclin-cdk activation. The model demonstrates repet-
itive cell cycling in the presence of suprathreshold amounts of growth factors.
The emphasis was on the Rb-E2F network during G1 phase and Cyclin A-
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dependent activation of Cyclin B during mitotic entry. Our model is also
structurally able to generate sustained oscillations like many other cell cycle
models (Csikasz-Nagy et al., 2006; Gerard and Goldbeter, 2009). However, the
focus of the model presented here is to simulate one or two cycles of cell divi-
sion observed during injury induced liver regeneration, and on the emerging
role of Cdh1 in regulating the cell cycle.
Threshold activation of Cyclin B
Entry to and exit from M phase display a switch-like behaviour in Cyclin B lev-
els. It is rapidly switched on at the G2-M phase transition and rapidly switched
off at the end of mitosis. Threshold activation provides a robust mechanism
for switch. We have shown that total Cyclin B concentration and activity is
regulated by two threshold processes: a transcritical bifurcation, mediated by
E2F and a bistable loop, mediated by APCCdh1. Both the transcritical bifur-
cation and the bistable loop allowed active Cyclin B to be kept at zero levels
outside the specific time window of activity during G2/M phases. Although
transcritical activation is qualitatively different from a bistable switch, it also
provides a sharp activation threshold.
Bandpass Filter of Damage Input
The model exhibits bandpass filter properties which allows the system to ig-
nore strong-transient and weak-sustained damages, as already discussed (Chauhan
et al., 2008). Thus, if the damage is too strong and transient or too weak, cells
will not enter the cell cycle events of DNA synthesis and mitosis. This is
in agreement with observations that liver regeneration is proportional to the
amount of PH but does not occur if the PH is too small or too large (Lambotte
et al., 1997). Also, varying the feedback strength of Cdh1-Cyclin A positive
feedback loop in the model tunes the range of filtering for Cyclin E and Cy-
clin B in an opposing manner. Such an opposite control of DNA synthesis and
mitosis with varying feedback strength of Cdh1-Cyclin A positive feedback
has not been systematically studied to our knowledge. Opposite control of
filtering range for Cyclin E and Cyclin B can have some interesting physio-
logical implications. Certain environmental conditions promote DNA synthesis
while suppress mitosis during endoreplication and polyploidization (Nevzorova
et al., 2009). Cdh1-mediated control of cyclins during endoreplication has been
widely reported in mammals, Drosophila and plants (Garcia-Higuera et al.,
2008; Sigrist and Lehner, 1997; Sorensen et al., 2000; Kasili et al., 2010). It
would be interesting to study Cdh1-mediated feedback loop control of cell cy-
cle with respect to endoreplication and polyploidisation, which are common
forms of cell cycle progression during liver regeneration (Duncan et al., 2010).
Circadian control of Wee1
Our model is consistent with a circadian control of Wee1 synthesis, affecting
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the timing of mitosis but not of DNA synthesis. When the entrainment to
light-dark cycle is simulated by varying Wee1 synthesis with a 24 h period,
the time at which PH is performed has a impact on the timing of mitosis. In
agreement with Matsuo et al (2003) results, we found that in PH performed at
ZT0 and ZT8 (at lights on and 8 hours later respectively), cells enter mitosis
roughly at the same time (around 60 h after ZT0). This shows that circadian
regulation of Wee1 induces a gating process by which cells cannot divide at
any time of the day. The timing of DNA synthesis was independent from the
timing of PH, and occurred 36 hours after PH, coherent with experimental
results. In hepatocytes, Wee1 is a major link between the circadian clock and
the cell cycle and S phase is largely a circadian clock-independent process,
despite the presence of a feedback loop linking G1/S and G2/M phases via
Cdh1 and SCF. In continuously dividing cells this independence might not be
preserved as gating mitosis might affect subsequent phases.
HGF treatments during S phase causes G2 delay
HGF accelerates cell cycle progression but has been mostly assumed to be non-
essential beyond G1-S transition. However, HGF injection at S phase leads to
a G2 delay resulting in delayed degradation of cyclins during G2-M phase.
The model was able to reproduce a G2 phase delay caused by growth factor
treatment during S phase marked with delayed degradation of Cyclin A and
Cyclin B. Erk signaling is known to mediate this G2 delay via CKI (Han
et al., 2005; Dangi et al., 2006; Park et al., 2007). Our simulations suggest
that CKI, APCCdh1 and E2F contribute in delaying the degradation of Cyclin
A and Cyclin B. This leads us to the conclusion that induction of growth
factors during S phase might lead to prolonged transcriptional activity of E2F
resulting in increased Cyclin A activity. Since the antagonistic Cyclin A and
APCCdh1 can not coexist, APCCdh1 is delayed. Thus the APCCdh1-dependent
degradation machinery might be responsible for the delayed Cyclin A and
Cyclin B degradation during G2 phase delay. Therefore, our model shows that
APCCdh1 might have a crucial role to play during G2 delay.
Conclusion
Mounting evidences demonstrate that Cdh1 plays a central role in the con-
trol of proliferation, differentiation and maintenance of genomic integrity by
timely and coordinated degradation of several substrates (Wasch et al., 2010).
Cdh1 maintains the stability of G1 phase by degrading the degradator of G1-
S cyclins and SCF. Cdh1 is also required for G2 DNA-damage checkpoint by
controlling the degradation of Cyclin A and Cyclin B (Wasch et al., 2010).
Cdh1 is also being implicated in genomic instability and cancers and is under
investigation as a therapeutic target. Recent developments call for a better
characterization of the role of Cdh1 in the control of G2 phase. It will be in-
teresting to dissect a Cdh1 based cell cycle model in order to understand the
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G2 delay and might help in better understanding of the fate of mitosis.
Also, owing to the role of Cdh1 in specialised cell division cycles of endorepli-
cation and polyploidy, widely observed during liver regeneration, a Cdh1 cen-
tered cell cycle model would be suitable to understand underlying mechanisms
controlling the causes and consequences of such specialised cell cycle events.
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Appendix
A Model equations
The model contains 25 dynamical variables and 84 parameters. The 25 variables
are the concentrations of the following players involved in the cell cycle control:
Damage (D) induced pro-inflammatory cytokine pathways (PIC and PGE); pro-
inflammatory cytokine induced growth factor pathways (PAI, HGF, HB-EGF); Cy-
clins D, E, A, and B; the inhibitor CKI and its complexes with the active cyclin-cdk
complexes; the active and inactive forms of phosphatase Cdc25 and of kinase Wee1;
the SCF proteasomal ligases involved in the degradation of cyclin D, Cyclin E and
CKI; and the active and inactive forms of the proteins Cdh1 and Cdc20 involved in
the degradation of cyclins A and B
A.1 G1-S model
[D] = I0 · e
−d0·t (A.1)
d[PIC]
dt
=
v1
1 + ( [PGE]
k−
1
)2
·
[D]
k1 + [D]
− d1 · [PIC] (A.2)
d[PGE]
dt
= v2 · [PIC]− d2 · [PGE] (A.3)
d[IEG]
dt
=
v3 · [PIC]
3
k33 + [PIC]
3
− d3 · [IEG] (A.4)
d[PAI]
dt
=
v4 · [PIC]
3
k34 + [PIC]
3
− d4 · [PAI] (A.5)
d[HGF ]
dt
=
v5 · [IEG]
1 + ( [PAI]
k−
5
)4
·
(
1 +
f5 · [HGF ]
k5 + [HGF ]
)
− d5[HGF ] (A.6)
d[HBEGF ]
dt
= v6 ·
[D]4
k461 + [D]
4
·
[IEG]
k62 + [IEG]
·
[HGF ]
k63 + [HGF ]
(A.7)
− d6[HBEGF ] (A.8)
d[CKI]
dt
= v7 ·
PIC
k7 + PIC
− d7 · [CKI]
−
d [CycD|CKI]
dt
−
d [CycE|CKI]
dt
−
d [CycA|CKI]
dt
(A.9)
d[CycD]
dt
=
v8 · [IEG] · [HGF ]
k8 + [IEG]
+ d10 · [CycD|CKI]
− (d8 · [SCF ] + v10 · [CKI]) · [CycD] (A.10)
d[CycE]
dt
=
v91 · [HBEGF ]
2
k291 + [HBEGF ]
2
+
v92 · [CycD]
4
k492 + [CycD]
4
+ d11 · [CycE|CKI]
15
− (d9 · [SCF ] + v11 · [CKI]) · [CycE] (A.11)
d[CycD|CKI]
dt
= v10[CKI][CycD]− d10[CycD|CKI] (A.12)
d[CycE|CKI]
dt
= v11[CKI][CycE]− d11[CycE|CKI] (A.13)
d [SCF ]
dt
= v12 · CycE − d122 · SCF · [APC|Cdh1] − d12 · SCF (A.14)
A.2 E2F steady state
Rb phosphorylation is initiated by Cyclin D, releasing E2F in sufficient quantity for
Cyclin E activation. Cyclin E further phosphorylates Rb (RbP ) resulting in hyper-
phosphorylated Rbpp, releasing higher amounts of E2F required for transcriptional
activation of further Cyclins. Phosphorylation/dephsophorylation reactions of Rb
and association/dissociation of its three phosphorylated forms with E2F are fast
enough to be in the steady state equilibrium.
[RbT ] = [Rb] + [Rbp] + [Rbpp] + [Rb ·E2F ] + [Rbp ·E2F ] + [Rbpp ·E2F ]
[E2FT ] = [E2F ] + [Rb ·E2F ] + [Rbp · E2F ] + [Rbpp · E2F ]
[Rbp] = p1 · [Rb] · [CycD]
[Rbpp] = p1p2 · [Rb] · [CycD] · [CycE]
[Rb · E2F ] = k1 · [Rb] · [E2F ]
[Rbp · E2F ] = p1k2 · [Rb] · [CycD] · [E2F ]
[Rbpp · E2F ] = p1p2k3 · [Rb] · [CycD] · [CycE] · [E2F ]
Substituting the steady state values, we solve the equation for E2F as
E2F =−
RbT − E2FT + C
2
+
√
(RbT − E2FT + C)
2
4
+ C, where (A.15)
C =
1 + p1 · [CycD] + p1p2 · [CycD] · [CycE]
k1 + k2p1 · [CycD] + k3p1p2 · [CycD] · [CycE]
A.3 APC steady state
[APCT ] = [APC] + [APC|Cdh1] + [APC|Cdc20p] (A.16)
[APC|Cdh1] = kCdh1APC · [Cdh1] · [APC] (A.17)
[APC|Cdc20p] = k
Cdc20
APC · [Cdc20p] · [APC] (A.18)
Substituting the steady state values, we solve the equation for APC as
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[APC] =
[APCT ]
1 + kCdh1APC · [Cdh1] + k
Cdc20
APC · [Cdc20p]
(A.19)
A.4 Cyclin B steady state
Cyclin B exists in two forms in our model: CycBact (active Cyclin B) and CycBinact
(inactive Cyclin B). Inactive Cyclin B equation is adapted from Pomerening et al.
(2005) with the simplification that the phosphorylation/dephosphorylation of the
three inactive forms of Cyclin B viz transcribed Cyclin B (CycB), Tyrosine phos-
phorylated (CycBY ), and Tyrosine and Threonine phosphorylated (CycBY T ) is
fast enough to be always in equilibrium; so that equation for CycBY T can be alge-
braically solved.
[CycBinact] = [CycB] + [CycB
Y ] + [CycBY T ] (A.20)
[CycB] = k2 ·
[Cdc25p]
[Wee1]
· [CycBY ] (A.21)
[
CycBY
]
= k1 ·
CycBY T
Wee1
(A.22)
[
CycBY T
]
=
CycBinact ·Wee1
2
Wee12 + k1 ·Wee1 + k1 · k2 · Cdc25p
(A.23)
A.5 Mitosis
d [CycA]
dt
= vE2FCA ·E2F − d
Cdh1
CA · [APC|Cdh1] · [CycA]
− dCA · [CycA]−
d [CycA|CKI]
dt
(A.24)
d [CycA|CKI]
dt
= vCKICA · [CycA] · [CKI]− d
CKI
CA · [CycA|CKI] (A.25)
d [CycBinact]
dt
= vE2FCB ·E2F − ka1 · [Cdc25p] ·
[
CycBY T
]
+PWee1CB · [Wee1] · [CycBact]− d
Cdh1
CB · [APC|Cdh1] · [CycBinact]
− dCdc20CB · [APC|Cdc20p] · [CycBinact]− dCB · [CycBinact] (A.26)
d
[
CycBTact
]
dt
=−PWee1CB · [Wee1] · [CycBact] + ka1 · [Cdc25p] ·
[
CycBY T
]
− dCdh1CB · [APC|Cdh1] · [CycBact]
− dCdc20CB · [APC|Cdc20p] · [CycBact]− dCB · [CycBact] (A.27)
d [Wee1]
dt
=Wee1b − P
CB
Wee1 · [CycBact] · [Wee1] + P
dephos
Wee1 · [Wee1p]
− dWee1 · [Wee1] (A.28)
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d [Wee1p]
dt
=PCBWee1 · [CycBact] · [Wee1]− P
dephos
Wee1 · [Wee1p]
− dWee1 · [Wee1p] (A.29)
d [Cdc25]
dt
=Cdc25b − P
CB
Cdc25 · [CycBact] · [Cdc25]
+ pdephosCdc25 · [Cdc25p]− dCdc25 · [Cdc25] (A.30)
d [Cdc25p]
dt
=PCBCdc25 · [CycBact] · [Cdc25] − P
dephos
Cdc25 · [Cdc25p]
− dCdc25 · [Cdc25p] (A.31)
d [Cdh1]
dt
=Cdh1b − P
CA
Cdh1 · [CycA] · [Cdh1]− P
CB
Cdh1 · [CycBact] · [Cdh1]
+P dephosCdh1 · [Cdh1p]− kCdh1 · [APC] · [Cdh1]
− dCdh1 · [Cdh1] (A.32)
d [Cdh1p]
dt
=PCACdh1 · [CycA] · [Cdh1] + P
CB
Cdh1 · [CycBact] · [Cdh1]
−P dephosCdh1 · [Cdh1p]− dCdh1 · [Cdh1p] (A.33)
d [Cdc20]
dt
=Cdc20b − P
CB
Cdc20 · [CycBact] · [Cdc20] + p
dephos
Cdc20 · [Cdc20p]
− dCdh1Cdc20 · [APC|Cdh1] · [Cdc20]− dCdc20 · [Cdc20] (A.34)
d [Cdc20p]
dt
=PCBCdc20 · [CycBact] · [Cdc20] − P
dephos
Cdc20 · [Cdc20p]
− dCdh1Cdc20 · [APC|Cdh1] · [Cdc20p]− kCdc20 · [APC] · [cdc20p]
− dCdc20 · [Cdc20p] (A.35)
A.6 Wee1 gated circadian regulation
d [Wee1]
dt
=Wee1c · (1 + sin(2pi/24 · (t− 6)))
−PCBWee1 · [CycBact] · [Wee1] + P
dephos
Wee1 · [Wee1p]
− dWee1 · [Wee1] (A.36)
A.7 HGF injection
d [HGF ] =
V IEGHGF · [IEG]
1 + ( [PAI]
KmPAI
HGF
4 )
· (1 +
f · [HGF ]
KmIEGHGF + [HGF ]
)
− dHGF · [HGF ] + hgfs · (t < 40) · (t > 36) (A.37)
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B Parameters
G1 − S
I0 4
d0 0.05
v1 1.5
k−1 0.9
k1 0.5
d1 0.5
v2 0.6
d2 0.006
v3 4.5
k3 0.7
d3 6
v4 45
k4 0.5
d4 6
v5 5
f5 5
k5 0.25
k−5 0.18
d5 0.05
v6 15
k61 0.9
k62 0.0005
k63 1.0
d6 0.05
v7 8
d7 8
v8 3
k8 0.001
d8 0.03
v91 5
k91 30
v92 5
k92 30
d9 0.01
v10 0.008
d10 0.0008
v11 2
d11 6
v12 0.56
d12 0.025
d122 0.75
E2F
E2FT 0.05
RbT 1
p1 3
p2 4
k1 25
k2 1
k3 0.1
APC
APCT 1
kCdh1APC 0.5
kCdc20APC 0.1
Mitosis
vE2FCA 1.75
dCdh1CA 1
dCA 0.1
vCKICA 0.01
dCKICA 0.1
k1 0.03
k2 5
ka1 60
vE2FCB 1.2
dCB 0.01
dCdh1CB 0.8
dCdc20CB 0.2
PWee1CB 8
Wee1b 1
dWee1 0.5
PCBWee1 3
P dephosWee1 0.02
Cdc25b 0.03
dCdc25 0.2
PCBCdc25 5
P dephosCdc25 0.3
Cdh1b 0.2
dCdh1 0.1
PCACdh1 0.2
PCBCdh1 0.01
P dephosCdh1 0.01
kCdh1 0.1
Cdc20b 15
dCdc20 0.005
dCdh1Cdc20 20
PCBCdc20 10
P dephosCdc20 0.01
kCdc20 0.1
HGFinjection
hgfs 0.4
Wee1 − gated
Wee1c 1.5
dphosCdc25 0.3
Bifurcation E2F
D 4
Bifurcation Cdh1
D 4
E2F 0.5
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Cyclin A Cyclin B
Cdc25
Cdc25Wee1
APC-Cdh1 APC-Cdc20
CKI E2F-FoxM1
Cytokines
Growth factors
Priming
G2/MM/G1
Damage
Fig. 1. Damage induced model of the cell cycle during liver regeneration based on
sequential cyclin activation and degradation. The PH-induced damage primes qui-
escent cells via cytokine signaling. Primed cells then activate growth factor-induced
signaling cascades. Cytokine- and growth factor-induced pathways act in concert
to provide mitogenic signals for Cyclin D activation in early G1 phase. Cyclin D
initiates a chain of sequential phosphorylation of Rb/E2F which leads to sequential
transcription of further G1-S (Cyclin E), S (Cyclin A) and M (Cyclin B) phase
cyclins. As early as G1 phase, stoichiometric inhibitors of cyclins, CKI, are also
activated by cytokines. The G1-S proteolytic degradation machinery, SCF, is acti-
vated by Cyclin E. Entry to mitosis is initiated by the abrupt activation of Cyclin B
by Cdc25 and Wee1 in a positive feedback loop fashion at G2-M transition. Cdc25-
and Wee1-mediated positive feedback loops also regulate the rapid exit from mitosis
by swiftly inactivating Cyclin B at M-G1 in coordination with a positive feedback
loop from the M-G1 degradator APCCdh1. Mitotic degradator APCCdc20 exerts a
negative feedback loop. All cyclin-cdk complexes are depicted by their respective
activating cyclin partner for simplicity. E2F in the scheme represents all three forms
of E2F, viz, unphosphorylated, hypophosphorylated and hyperphosphorylated
.
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Fig. 2. Sequential activation and degradation of cyclins and their key regulators.
Cyclin D appears at the late G1, Cyclin E at the G1-S transition, Cyclin A in
the S phase and Cyclin B in the late S phase and mitosis. At the G2-M interface,
transient activation of Cyclin B active, Cdc25 and inactivation of Wee1, leads to
abrupt mitotic entry. At the M-G1 interface, Cdc25 and Wee1 are respectively
rapidly inactivated and activated, leading to swift exit from mitosis. APCCdc20
is also transiently activated once enough Cyclin B has accumulated at mitosis.
APCCdh1 is active from late mitosis to G1 phase keeping Cyclin A and Cyclin B
degraded in a positive feedback loop fashion during late mitosis and G1. SCF is
activated by Cyclin E during G1-S phase leading to degradation of G1-S cyclins.
All concentrations are normalized by their maximum concentrations.
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Fig. 3. Threshold activation of Cyclin B driving M phase progression. (a) Bifurcation
diagram with respect to E2F activity. Steady states in Cyclin B activity are plotted
as a function of E2F activity. At any E2F level, Cyclin B activity has two steady
states, one zero and one either negative or positive. The two steady states exchange
their stability when they meet. The largest (zero or positive) steady state is always
stable and the smallest always unstable. (b) Bifurcation diagram with respect to the
degradation rate dCdh1CB . Steady states in Cyclin B activity are plotted as a function
of the degradation rate dCdh1CB . Over a large range of degradation rates, Cyclin B
activity has two stable steady states. In a and b, thick solid lines represent stable
steady states and dashed lines, unstable steady states. The vertical lines represent
the set values of E2F and dCdh1CB for the bifurcation diagrams for d
Cdh1
CB and E2F
respectively.
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Fig. 4. Bandpass filter characteristics of the model. Both DNA synthesis (Cyclin
E) (b, top) and mitosis (Cyclin B) (c, top) exhibit bandpass filtering properties
when the damage (a) is changed systematically from weak-sustained damage to
strong-transient damage, keeping the total amount of damage constant. Timing
remains relatively constant (b and c, bottom).
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Fig. 5. Opposite bandpass filtering effect on DNA synthesis (a) and mitosis (b) with
respect to changing feedback strength of Cdh1-Cyclin A loop.
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Fig. 6. Cyclin B (a) and Wee1 (b) activity in response to PH performed at different
times of the day (ZT8 represents 8 hours after light is on; ZT0 represents 0 hour
after light is on, in a 12 h light-dark cycle). In ZT8 mice, Wee1 peaks 8 hours earlier
than in ZT0 mice; that leads to a 7.5 hour-advanced peak of Cyclin B activity.
Cyclin E (c) shows no change in activity between ZT0 and ZT8.
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Fig. 7. Growth factor induction at S phase delays G2 phase. Induction of HGF
at Spahse (a) leads to delay in the degradation of Cyclin A (e) and Cyclin B (f).
CKI (b), E2F (c) and APCCdh1 (d) contribute together in causing this delayed
degradation of G2-M cyclins.
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